Cultivation Capital

Cultivation Capital is a venture capital firm based in Saint Louis, Missouri, founded in 2012. The firm specializes in early-stage investments, primarily targeting Seed and Series A funding rounds. Cultivation Capital focuses on technology companies across various sectors, including life sciences, health technology, software, information technology, agriculture technology, food technology, and geospatial technology. The firm typically invests between $500,000 and $3.5 million in its initial funding rounds, aiming to support innovative startups that have the potential to make significant impacts in their respective industries. As a Registered Investment Adviser, Cultivation Capital plays a crucial role in nurturing and financing the growth of emerging companies.

Andy Dearing

General Partner

Peter Esparrago

General Partner and Co-Founder

Taha Jangda

General Partner

Paul Meier

Partner

Tim Stern

General Partner

John True

General Partner

Dean VandeKamp

General Partner

Paul Weber

General Partner

Kyle Welborn

Co-Founder and General Partner

Heather Wood

General Partner

Jared Winegrad

Principal

Past deals in Midwestern US

Matic Insurance

Series B in 2023
Matic Insurance Services, Inc. is a digital insurance agency based in Columbus, Ohio, with additional offices in California and Ukraine. Established in 2014, Matic has transformed the insurtech landscape by integrating insurance solutions into the home and auto ownership experience. The company's digital marketplace features over 40 A-rated home and auto insurance carriers and collaborates with various distribution partners across mortgage originations, banking, real estate, and personal finance. Matic prioritizes policyholder advocacy by offering a straightforward and transparent comparison shopping process, which enables customers to save significant time and reduce their premiums by more than 30% annually. Through its platform, Matic provides a seamless experience for homeowners to analyze property data and compare insurance quotes efficiently.

AirDeck

Seed Round in 2023
AirDeck, Inc. is a software-as-a-service (SaaS) company that provides an online platform for creating narrated presentations and documents intended for on-demand viewing. Founded in 2019 and based in Madison, Wisconsin, AirDeck's platform allows users to personalize their content, embed and share presentations, and record individual slides with audio and video. It also offers features such as viewer analytics, secure document sharing, and real-time chat, making it a versatile tool for various applications, including education, sales, investor relations, board meetings, webinars, online training, thought leadership, and employee onboarding.

Clever Real Estate

Venture Round in 2023
Clever Real Estate is a company that specializes in the fields of commercial real estate and online marketplaces. It offers a software platform that guides its users through the process of interviewing real estate agents to find the right one for them. The company was founded in 2017 and is headquartered in St Louis, Missouri.

SimpleRose

Venture Round in 2023
SimpleRose Inc. is a technology company based in Saint Louis, Missouri, that specializes in developing a prescriptive analytics platform aimed at enhancing decision-making processes in complex environments. Founded in 2018, the company's solutions focus on optimizing operations through applications such as scheduling, production planning, and portfolio optimization. By leveraging algorithmic innovations for improved numerical accuracy and speed, SimpleRose enables organizations to tackle intricate operational challenges and make informed decisions in real-time.

Mission Control

Seed Round in 2022
Mission Control is a mobile app where gamers can join recreational eSports leagues, similar to their local adult softball league or college intramurals but for video games. Gamers can choose to join a league of just friends or decide to compete in a league hosted by a local organization. Mission Control manages the league schedule, validates scores, and determines the champion while also serving as a forum for league members and friends. Organizations, whether a community group, college, LAN Center, or something else, can use Mission Control to gather a following, host leagues of various game titles, and manage their eSports’ operations. Mission Control is a platform for recreational esports, a place where gamers can play in video game leagues for friends.

Geneoscopy

Series B in 2021
Geneoscopy, LLC, based in Saint Louis, Missouri, specializes in developing non-invasive diagnostic tests aimed at preventing, detecting, and guiding treatment for gastrointestinal diseases, particularly colorectal cancer. Founded in 2015, the company utilizes a proprietary platform that extracts stool-derived eukaryotic RNA (seRNA) to create a multi-target RNA biomarker panel. This innovative approach allows for the identification of colorectal cancer by capturing the effects of DNA mutations associated with the disease. Geneoscopy's technology not only enhances screening compliance but also facilitates the early detection of colorectal neoplasms, ultimately aiming to reduce morbidity and mortality linked to colorectal cancer. The company is also exploring additional applications of its technology for related gastrointestinal conditions.

Clever Real Estate

Venture Round in 2021
Clever Real Estate is a company that specializes in the fields of commercial real estate and online marketplaces. It offers a software platform that guides its users through the process of interviewing real estate agents to find the right one for them. The company was founded in 2017 and is headquartered in St Louis, Missouri.

Balto

Series B in 2021
Balto Software Inc. is a developer of sales software that leverages artificial intelligence and real-time conversation analytics to enhance the performance of sales representatives during phone calls. Founded in 2017 and based in Saint Louis, Missouri, Balto's platform offers agents live guidance by alerting them to mistakes and providing suggestions tailored to specific products, phrases, and industry terminology. The software monitors conversations for compliance and quality, allowing representatives to self-correct in real time, while also equipping managers with tools to oversee key behaviors. Balto's solutions support various functions, including sales leadership, customer service, and compliance, and have guided over 150 million calls, resulting in substantial revenue increases and high customer ratings. The company is trusted by numerous contact centers, helping to prevent missed sales opportunities and improve customer experiences.

Reconstruct

Series B in 2021
Reconstruct, Inc. specializes in predictive computer vision data analytics software tailored for construction projects. Its visual production management platform facilitates data collection through drones, fixed cameras, or mobile devices, enabling effective progress analysis and documentation. By visualizing images and 3D points aligned with Building Information Modeling (BIM), the platform enhances coordination and transparency among project stakeholders. It identifies locations at risk of delays, allowing for proactive weekly work planning, and integrates schedules with BIM animations to illustrate any changes in plans. Founded in 2016 and headquartered in Menlo Park, California, with an additional office in Champaign, Illinois, Reconstruct aims to improve construction management by fostering better communication and visibility, thereby mitigating risks and ensuring project returns on investment.

SentiAR

Series A in 2021
SentiAR, Inc. is a digital health company based in St. Louis, Missouri, specializing in 3D augmented reality solutions for interventional medical procedures. Founded in 2017 as a spin-off from Washington University, SentiAR has developed a platform that offers real-time holographic visualization of patients' anatomical structures and catheter locations. This technology integrates data from CT, MRI, and real-time mapping systems to create a controllable 3D holographic interface. The platform aims to enhance the delivery of care by allowing clinicians to visualize complex cardiac anatomy directly over the patient, thereby improving the treatment of cardiac arrhythmias during catheterization procedures. SentiAR is in the process of preparing its platform for submission to the FDA.

iSite Media

Seed Round in 2021
iSite Media, LLC specializes in advertising and marketing services utilizing digital display technology. Founded in 2015 and based in St. Louis, Missouri, the company focuses on delivering brand promotion through digital display networks located in restrooms. This unique placement allows for high visibility and relevance, enhancing consumer recall and engagement. iSite Media bridges the gap between content and consumers, ensuring that advertisements reach the appropriate audience in various environments outside the home. In 2017, the company rebranded from its former name, Sitting Duck Advertising, to better reflect its innovative approach to media campaigns.

AirDeck

Seed Round in 2020
AirDeck, Inc. is a software-as-a-service (SaaS) company that provides an online platform for creating narrated presentations and documents intended for on-demand viewing. Founded in 2019 and based in Madison, Wisconsin, AirDeck's platform allows users to personalize their content, embed and share presentations, and record individual slides with audio and video. It also offers features such as viewer analytics, secure document sharing, and real-time chat, making it a versatile tool for various applications, including education, sales, investor relations, board meetings, webinars, online training, thought leadership, and employee onboarding.

FinLocker

Series A in 2020
FinLocker, LLC is a financial technology company founded in 2014 and based in St. Louis, Missouri. It develops a consumer-enabled financial data platform that facilitates the loan process for mortgages and other financial products. The platform serves both businesses and consumers by streamlining loan transactions and enhancing the overall financial experience. For businesses, FinLocker provides tools that cut costs, reduce fraud, and mitigate risks while improving customer satisfaction and operational efficiency. For consumers, the platform simplifies the loan application process, minimizes paperwork, and enables better management of personal finances. Using consumer consent, FinLocker captures essential borrower data and employs intelligent analytics to offer tailored loan product recommendations based on individual financial profiles.

Balto

Series A in 2020
Balto Software Inc. is a developer of sales software that leverages artificial intelligence and real-time conversation analytics to enhance the performance of sales representatives during phone calls. Founded in 2017 and based in Saint Louis, Missouri, Balto's platform offers agents live guidance by alerting them to mistakes and providing suggestions tailored to specific products, phrases, and industry terminology. The software monitors conversations for compliance and quality, allowing representatives to self-correct in real time, while also equipping managers with tools to oversee key behaviors. Balto's solutions support various functions, including sales leadership, customer service, and compliance, and have guided over 150 million calls, resulting in substantial revenue increases and high customer ratings. The company is trusted by numerous contact centers, helping to prevent missed sales opportunities and improve customer experiences.

Matic Insurance

Series B in 2020
Matic Insurance Services, Inc. is a digital insurance agency based in Columbus, Ohio, with additional offices in California and Ukraine. Established in 2014, Matic has transformed the insurtech landscape by integrating insurance solutions into the home and auto ownership experience. The company's digital marketplace features over 40 A-rated home and auto insurance carriers and collaborates with various distribution partners across mortgage originations, banking, real estate, and personal finance. Matic prioritizes policyholder advocacy by offering a straightforward and transparent comparison shopping process, which enables customers to save significant time and reduce their premiums by more than 30% annually. Through its platform, Matic provides a seamless experience for homeowners to analyze property data and compare insurance quotes efficiently.

Avail

Series A in 2020
Avail is an online platform designed to simplify the rental and leasing process for independent landlords and property managers. Founded in 2012 and based in Chicago, Illinois, the company provides a comprehensive suite of services including rental listings, tenant screening, customized leases, online rent payments, maintenance tracking, and rent price analysis. Avail addresses a gap in the market by offering tools specifically tailored for landlords managing fewer than ten rental units, enabling them to effectively navigate the rental cycle. The platform facilitates the advertising of vacant properties, processing of rental applications, collection of credit reports, signing of leases, and management of maintenance requests, all through an intuitive interface. With a user base of 70,000 landlords, Avail serves as a critical resource for those looking to scale their property management efforts from beginner to professional levels, while also being a subsidiary of Move, Inc. since December 2020.

Mission Control

Seed Round in 2020
Mission Control is a mobile app where gamers can join recreational eSports leagues, similar to their local adult softball league or college intramurals but for video games. Gamers can choose to join a league of just friends or decide to compete in a league hosted by a local organization. Mission Control manages the league schedule, validates scores, and determines the champion while also serving as a forum for league members and friends. Organizations, whether a community group, college, LAN Center, or something else, can use Mission Control to gather a following, host leagues of various game titles, and manage their eSports’ operations. Mission Control is a platform for recreational esports, a place where gamers can play in video game leagues for friends.

iSite Media

Seed Round in 2020
iSite Media, LLC specializes in advertising and marketing services utilizing digital display technology. Founded in 2015 and based in St. Louis, Missouri, the company focuses on delivering brand promotion through digital display networks located in restrooms. This unique placement allows for high visibility and relevance, enhancing consumer recall and engagement. iSite Media bridges the gap between content and consumers, ensuring that advertisements reach the appropriate audience in various environments outside the home. In 2017, the company rebranded from its former name, Sitting Duck Advertising, to better reflect its innovative approach to media campaigns.

SentiAR

Venture Round in 2020
SentiAR, Inc. is a digital health company based in St. Louis, Missouri, specializing in 3D augmented reality solutions for interventional medical procedures. Founded in 2017 as a spin-off from Washington University, SentiAR has developed a platform that offers real-time holographic visualization of patients' anatomical structures and catheter locations. This technology integrates data from CT, MRI, and real-time mapping systems to create a controllable 3D holographic interface. The platform aims to enhance the delivery of care by allowing clinicians to visualize complex cardiac anatomy directly over the patient, thereby improving the treatment of cardiac arrhythmias during catheterization procedures. SentiAR is in the process of preparing its platform for submission to the FDA.

Textel

Seed Round in 2019
Textel CX Inc. is a company based in Saint Louis, Missouri, that specializes in developing a cloud-based texting platform tailored for contact centers and various businesses. Founded in 2014, Textel offers services such as landline texting, API integrations, and Text-to-Find functionalities for sectors including car dealerships, insurance, salons, pet grooming, medical, and legal offices. With a customer base of nearly 800 across North America, Textel enhances customer engagement and operational efficiency by facilitating inbound and outbound SMS and MMS communications. The platform allows businesses to utilize their existing phone numbers while integrating seamlessly with popular systems of record, thereby enabling secure and efficient communication through both computer and mobile devices.

Healthy Bytes

Series A in 2019
Healthy Bytes, Inc. develops a software platform that facilitates personalized nutritional counseling, connecting physicians, employers, and patients. Founded in 2014 and headquartered in Saint Louis, Missouri, with an additional office in New York, the company employs registered dietitians who provide consultations to employees seeking medical care for conditions such as obesity, diabetes, high blood pressure, and cardiovascular diseases. The platform enables users to book private consultations and allows dietitians to monitor their clients' eating habits. By leveraging existing medical benefits, employees can access nutritional counseling without incurring additional costs, promoting healthier lifestyles through expert dietary guidance.

Emplify

Series B in 2019
Emplify is a prominent software-as-a-service company specializing in employee engagement measurement. Founded in 2010 and based in Fishers, Indiana, Emplify provides a platform that allows executives to solicit, analyze, and act upon employee feedback, effectively translating data insights into actionable strategies. The company employs scientific methodologies and psychometrics to enhance workplace engagement. Emplify distinguishes itself by integrating survey insights with employee communication and performance improvement, creating a comprehensive engagement system designed to foster organizational transformation.

Geneoscopy

Series A in 2019
Geneoscopy, LLC, based in Saint Louis, Missouri, specializes in developing non-invasive diagnostic tests aimed at preventing, detecting, and guiding treatment for gastrointestinal diseases, particularly colorectal cancer. Founded in 2015, the company utilizes a proprietary platform that extracts stool-derived eukaryotic RNA (seRNA) to create a multi-target RNA biomarker panel. This innovative approach allows for the identification of colorectal cancer by capturing the effects of DNA mutations associated with the disease. Geneoscopy's technology not only enhances screening compliance but also facilitates the early detection of colorectal neoplasms, ultimately aiming to reduce morbidity and mortality linked to colorectal cancer. The company is also exploring additional applications of its technology for related gastrointestinal conditions.

Balto

Seed Round in 2019
Balto Software Inc. is a developer of sales software that leverages artificial intelligence and real-time conversation analytics to enhance the performance of sales representatives during phone calls. Founded in 2017 and based in Saint Louis, Missouri, Balto's platform offers agents live guidance by alerting them to mistakes and providing suggestions tailored to specific products, phrases, and industry terminology. The software monitors conversations for compliance and quality, allowing representatives to self-correct in real time, while also equipping managers with tools to oversee key behaviors. Balto's solutions support various functions, including sales leadership, customer service, and compliance, and have guided over 150 million calls, resulting in substantial revenue increases and high customer ratings. The company is trusted by numerous contact centers, helping to prevent missed sales opportunities and improve customer experiences.

Dynamo Metrics

Seed Round in 2019
Dynamo Metrics, LLC specializes in designing and developing data applications for local governments, including county treasurers, land banks, and municipalities. Founded in 2005 and headquartered in Ann Arbor, Michigan, the company offers a suite of cloud-based products such as Neighborhood Intel, which consolidates various federal, state, and city data into a single application. It also provides a customizable Public Portal for sharing insights with citizens and a Code Enforcement tool for managing compliance efforts. Additionally, Dynamo Metrics supports municipalities in decision-making, reporting, and analysis, helping them measure options, secure funding, and develop quality reports. By leveraging technology and personalized service, the company aims to enhance community development and economic planning, enabling local governments to make informed decisions based on data rather than anecdotes.

DemandJump

Series A in 2019
DemandJump Inc. operates a marketing intelligence software platform that provides marketers with actionable insights derived from both online and offline data. Founded in 2015 and based in Indianapolis, Indiana, the company offers a suite of tools, including Traffic Cloud, which identifies effective sources of traffic and revenue for brands, and Account-Based Attribution, which allows marketing and sales teams to evaluate the revenue impact of various customer touchpoints. Utilizing artificial intelligence, DemandJump aggregates and analyzes competitive digital data to reveal market trends and audience behaviors, facilitating more informed decision-making for customer acquisition and marketing strategy. The platform aims to enhance website traffic, generate leads, and ultimately drive revenue growth while optimizing marketing expenditures.

Clever Real Estate

Series A in 2019
Clever Real Estate is a company that specializes in the fields of commercial real estate and online marketplaces. It offers a software platform that guides its users through the process of interviewing real estate agents to find the right one for them. The company was founded in 2017 and is headquartered in St Louis, Missouri.

Reconstruct

Series A in 2019
Reconstruct, Inc. specializes in predictive computer vision data analytics software tailored for construction projects. Its visual production management platform facilitates data collection through drones, fixed cameras, or mobile devices, enabling effective progress analysis and documentation. By visualizing images and 3D points aligned with Building Information Modeling (BIM), the platform enhances coordination and transparency among project stakeholders. It identifies locations at risk of delays, allowing for proactive weekly work planning, and integrates schedules with BIM animations to illustrate any changes in plans. Founded in 2016 and headquartered in Menlo Park, California, with an additional office in Champaign, Illinois, Reconstruct aims to improve construction management by fostering better communication and visibility, thereby mitigating risks and ensuring project returns on investment.

Avail

Venture Round in 2019
Avail is an online platform designed to simplify the rental and leasing process for independent landlords and property managers. Founded in 2012 and based in Chicago, Illinois, the company provides a comprehensive suite of services including rental listings, tenant screening, customized leases, online rent payments, maintenance tracking, and rent price analysis. Avail addresses a gap in the market by offering tools specifically tailored for landlords managing fewer than ten rental units, enabling them to effectively navigate the rental cycle. The platform facilitates the advertising of vacant properties, processing of rental applications, collection of credit reports, signing of leases, and management of maintenance requests, all through an intuitive interface. With a user base of 70,000 landlords, Avail serves as a critical resource for those looking to scale their property management efforts from beginner to professional levels, while also being a subsidiary of Move, Inc. since December 2020.

Fifth Eye

Series A in 2019
Fifth Eye Inc. is a medical software company that specializes in developing real-time analytics systems for monitoring hemodynamic instability in patients. The company's innovative software continuously analyzes a patient's clinical data to provide early warnings of potential health issues, allowing healthcare professionals to intervene proactively. It delivers rapid assessments, with initial scoring in just five minutes, and offers continuous monitoring without the need for baseline data or integration with electronic health records. By utilizing advanced artificial intelligence and real-time ECG data, Fifth Eye's system enhances clinical decision-making, aiming to improve patient outcomes, prevent adverse events, and reduce hospital stays and costs. Founded in 2017 and based in Ann Arbor, Michigan, Fifth Eye was previously known as Trove Analytics, Inc., before rebranding in June 2018.

Well Principled

Pre Seed Round in 2019
Well Principled is an A.I. Management Consultant that predicts the buying behavior of every customer, optimizing the marketing and supply chain processes for retail and CPG brands. The software gives businesses clear plans of action based on theory-backed models mined from the academic business literature and modern A.I. platform. It provides firms with an alternative to muddling through process optimization with headcount-intensive armies of analysts, custom development teams that have to reinvent the wheel, or management consultants who produce recommendations but not results. Well Principled was founded in 2018 and is based in St. Louis, Missouri.

Arch Oncology

Series B in 2019
Arch Oncology, Inc. is an immuno-oncology company focused on discovering and developing antibody therapeutics for the treatment of solid tumors and hematologic cancers. Established in 2006 and headquartered in Brisbane, California, with a research laboratory in St. Louis, Missouri, the company specializes in anti-CD47 antibodies that represent a novel class of checkpoint inhibitors. These second-generation antibodies are designed to engage both the adaptive and innate immune systems, effectively targeting and killing tumor cells. By harnessing the body's immune response, Arch Oncology aims to provide new treatment options for patients battling cancer.

Clever Real Estate

Venture Round in 2018
Clever Real Estate is a company that specializes in the fields of commercial real estate and online marketplaces. It offers a software platform that guides its users through the process of interviewing real estate agents to find the right one for them. The company was founded in 2017 and is headquartered in St Louis, Missouri.

Covercress

Venture Round in 2018
CoverCress Inc. is a biotechnology company based in St. Louis, Missouri, focused on developing and commercializing field pennycress as an oilseed crop. Founded in 2013, the company aims to produce oil for industrial and renewable fuels, as well as meal for nutritious livestock feed. CoverCress specializes in crop breeding services that enhance soil cover during corn harvest and soybean planting, allowing farmers to maximize yields through sustainable agricultural practices. The company is dedicated to utilizing low-input methods to create a feedstock for low carbon intensity biofuels, contributing to more efficient and environmentally friendly agricultural solutions.

CardiaLen

Series B in 2018
CardiaLen, Inc. is a medical device company based in Minneapolis, Minnesota, specializing in the development of innovative therapies for atrial fibrillation and other heart arrhythmias. Founded in 2008, the company is focused on creating implantable, low-energy cardioverter devices that offer pain-free cardioversion therapies. These devices monitor the heartbeat and employ a proprietary series of low-energy pulses to restore normal heart rhythm while minimizing discomfort and preventing damage to heart tissue. By addressing significant unmet needs in the treatment of atrial fibrillation, CardiaLen aims to enhance patient outcomes and reduce reliance on high-energy defibrillation shocks.

SimpleRose

Venture Round in 2018
SimpleRose Inc. is a technology company based in Saint Louis, Missouri, that specializes in developing a prescriptive analytics platform aimed at enhancing decision-making processes in complex environments. Founded in 2018, the company's solutions focus on optimizing operations through applications such as scheduling, production planning, and portfolio optimization. By leveraging algorithmic innovations for improved numerical accuracy and speed, SimpleRose enables organizations to tackle intricate operational challenges and make informed decisions in real-time.

Emplify

Venture Round in 2018
Emplify is a prominent software-as-a-service company specializing in employee engagement measurement. Founded in 2010 and based in Fishers, Indiana, Emplify provides a platform that allows executives to solicit, analyze, and act upon employee feedback, effectively translating data insights into actionable strategies. The company employs scientific methodologies and psychometrics to enhance workplace engagement. Emplify distinguishes itself by integrating survey insights with employee communication and performance improvement, creating a comprehensive engagement system designed to foster organizational transformation.

iSite Media

Seed Round in 2018
iSite Media, LLC specializes in advertising and marketing services utilizing digital display technology. Founded in 2015 and based in St. Louis, Missouri, the company focuses on delivering brand promotion through digital display networks located in restrooms. This unique placement allows for high visibility and relevance, enhancing consumer recall and engagement. iSite Media bridges the gap between content and consumers, ensuring that advertisements reach the appropriate audience in various environments outside the home. In 2017, the company rebranded from its former name, Sitting Duck Advertising, to better reflect its innovative approach to media campaigns.

FinLocker

Seed Round in 2018
FinLocker, LLC is a financial technology company founded in 2014 and based in St. Louis, Missouri. It develops a consumer-enabled financial data platform that facilitates the loan process for mortgages and other financial products. The platform serves both businesses and consumers by streamlining loan transactions and enhancing the overall financial experience. For businesses, FinLocker provides tools that cut costs, reduce fraud, and mitigate risks while improving customer satisfaction and operational efficiency. For consumers, the platform simplifies the loan application process, minimizes paperwork, and enables better management of personal finances. Using consumer consent, FinLocker captures essential borrower data and employs intelligent analytics to offer tailored loan product recommendations based on individual financial profiles.

DemandJump

Series A in 2018
DemandJump Inc. operates a marketing intelligence software platform that provides marketers with actionable insights derived from both online and offline data. Founded in 2015 and based in Indianapolis, Indiana, the company offers a suite of tools, including Traffic Cloud, which identifies effective sources of traffic and revenue for brands, and Account-Based Attribution, which allows marketing and sales teams to evaluate the revenue impact of various customer touchpoints. Utilizing artificial intelligence, DemandJump aggregates and analyzes competitive digital data to reveal market trends and audience behaviors, facilitating more informed decision-making for customer acquisition and marketing strategy. The platform aims to enhance website traffic, generate leads, and ultimately drive revenue growth while optimizing marketing expenditures.

SentiAR

Convertible Note in 2018
SentiAR, Inc. is a digital health company based in St. Louis, Missouri, specializing in 3D augmented reality solutions for interventional medical procedures. Founded in 2017 as a spin-off from Washington University, SentiAR has developed a platform that offers real-time holographic visualization of patients' anatomical structures and catheter locations. This technology integrates data from CT, MRI, and real-time mapping systems to create a controllable 3D holographic interface. The platform aims to enhance the delivery of care by allowing clinicians to visualize complex cardiac anatomy directly over the patient, thereby improving the treatment of cardiac arrhythmias during catheterization procedures. SentiAR is in the process of preparing its platform for submission to the FDA.

Noonlight

Seed Round in 2017
Noonlight, Inc. is a company that specializes in personal safety through its mobile application, which connects various Internet of Things (IoT) devices to enhance user protection. Founded in 2013 and headquartered in Saint Louis, Missouri, Noonlight's platform provides 24/7 professional monitoring and data-driven emergency response capabilities. The application enables users to create accounts and connect multiple devices, allowing for precise location detection in emergencies. In critical situations, it can alert authorities without necessitating a 911 call or verbal communication. Noonlight's technology is operational across the United States, making it a versatile tool for enhancing personal safety and comfort.

Cheddar

Seed Round in 2017
Cheddar, founded in 2008 and headquartered in Bloomington, Indiana, is a billing and recurring subscription management platform tailored for Software as a Service (SaaS) companies. The company offers a comprehensive solution that simplifies the complexities of billing and collections, including pricing, processing, customer communications, and revenue optimization. By replacing outdated billing methods with a modern, usage-based model, Cheddar enables businesses to efficiently manage recurring revenue and track real-time metrics. Its platform supports various payment structures, allowing companies to accept and monitor recurring payments, one-time charges, and usage fees, ultimately driving growth in top-line revenue.

Avail

Seed Round in 2017
Avail is an online platform designed to simplify the rental and leasing process for independent landlords and property managers. Founded in 2012 and based in Chicago, Illinois, the company provides a comprehensive suite of services including rental listings, tenant screening, customized leases, online rent payments, maintenance tracking, and rent price analysis. Avail addresses a gap in the market by offering tools specifically tailored for landlords managing fewer than ten rental units, enabling them to effectively navigate the rental cycle. The platform facilitates the advertising of vacant properties, processing of rental applications, collection of credit reports, signing of leases, and management of maintenance requests, all through an intuitive interface. With a user base of 70,000 landlords, Avail serves as a critical resource for those looking to scale their property management efforts from beginner to professional levels, while also being a subsidiary of Move, Inc. since December 2020.

Covercress

Venture Round in 2017
CoverCress Inc. is a biotechnology company based in St. Louis, Missouri, focused on developing and commercializing field pennycress as an oilseed crop. Founded in 2013, the company aims to produce oil for industrial and renewable fuels, as well as meal for nutritious livestock feed. CoverCress specializes in crop breeding services that enhance soil cover during corn harvest and soybean planting, allowing farmers to maximize yields through sustainable agricultural practices. The company is dedicated to utilizing low-input methods to create a feedstock for low carbon intensity biofuels, contributing to more efficient and environmentally friendly agricultural solutions.

BenchmarkONE

Series A in 2017
BenchmarkONE develops sales and marketing automation software tailored for small and mid-sized businesses. The company offers an integrated platform that includes customer relationship management (CRM) tools and sales automation features, allowing users to monitor contacts' activities, track deals, manage communications, and segment their audience. Additionally, BenchmarkONE provides email marketing capabilities with a user-friendly drag-and-drop email builder and marketing automation tools designed to engage visitors, prioritize leads, and optimize campaign investments. Originally known as Hatchbuck, Inc., the company rebranded to BenchmarkONE in June 2020 and has been operational since 2010, with its headquarters in St. Louis, Missouri. As of September 2019, BenchmarkONE functions as a subsidiary of Benchmark Internet Group, LLC.

Euclises Pharmaceuticals

Venture Round in 2016
Euclises Pharmaceuticals, Inc. is engaged in the research, development, and commercialization of innovative medicines targeting inflammation and oncology. Founded in 2011 and headquartered in Saint Louis, Missouri, the company focuses on creating novel pain and cancer medications that promise enhanced safety profiles compared to current therapies. The firm is built on pioneering inventions by Dr. John Talley, a renowned medicinal chemist known for developing Celebrex among other approved drugs. Euclises aims to introduce new compounds that provide improved efficacy and safety, positioning itself as a leader in the pharmaceutical industry. The company operates from the BioGenerator Accelerator Labs, where it continues to advance its research initiatives.

FinLocker

Seed Round in 2016
FinLocker, LLC is a financial technology company founded in 2014 and based in St. Louis, Missouri. It develops a consumer-enabled financial data platform that facilitates the loan process for mortgages and other financial products. The platform serves both businesses and consumers by streamlining loan transactions and enhancing the overall financial experience. For businesses, FinLocker provides tools that cut costs, reduce fraud, and mitigate risks while improving customer satisfaction and operational efficiency. For consumers, the platform simplifies the loan application process, minimizes paperwork, and enables better management of personal finances. Using consumer consent, FinLocker captures essential borrower data and employs intelligent analytics to offer tailored loan product recommendations based on individual financial profiles.

Salesvue

Venture Round in 2016
Salesvue, LLC, founded in 2006 and based in Indianapolis, Indiana, provides salesforce automation software designed to enhance productivity for sales teams. Originally known as Jesubi, the company rebranded in 2013 to focus on its prospect-to-pipeline automation solution. Salesvue's software serves as a sales enablement tool for Salesforce.com users, addressing the often unstructured prospecting phase of the sales cycle. By employing empirical data, Salesvue enables strategic decision-making, enhancing the effectiveness of sales executives and managers alike. The platform facilitates collaboration among marketing, sales, and onboarding teams, streamlining communication and accountability throughout the sales process. With its native Salesforce AppX solution, Salesvue helps organizations implement proven prospecting methodologies, aiming to boost a salesperson's daily calling throughput significantly while providing valuable analytics for sales management.

CardiaLen

Venture Round in 2016
CardiaLen, Inc. is a medical device company based in Minneapolis, Minnesota, specializing in the development of innovative therapies for atrial fibrillation and other heart arrhythmias. Founded in 2008, the company is focused on creating implantable, low-energy cardioverter devices that offer pain-free cardioversion therapies. These devices monitor the heartbeat and employ a proprietary series of low-energy pulses to restore normal heart rhythm while minimizing discomfort and preventing damage to heart tissue. By addressing significant unmet needs in the treatment of atrial fibrillation, CardiaLen aims to enhance patient outcomes and reduce reliance on high-energy defibrillation shocks.

Arch Oncology

Series A in 2016
Arch Oncology, Inc. is an immuno-oncology company focused on discovering and developing antibody therapeutics for the treatment of solid tumors and hematologic cancers. Established in 2006 and headquartered in Brisbane, California, with a research laboratory in St. Louis, Missouri, the company specializes in anti-CD47 antibodies that represent a novel class of checkpoint inhibitors. These second-generation antibodies are designed to engage both the adaptive and innate immune systems, effectively targeting and killing tumor cells. By harnessing the body's immune response, Arch Oncology aims to provide new treatment options for patients battling cancer.

BlueStrata EHR

Seed Round in 2016
BlueStrata EHR is a St. Louis-based company that specializes in developing a cloud-based electronic health records (EHR) software platform tailored for long-term care and resident care facilities. The platform integrates clinical, financial, and point-of-care services, facilitating seamless data sharing across medical records and billing systems. BlueStrata EHR's intuitive design incorporates easily accessible touch screen kiosks, allowing caregivers to capture accurate resident care information from any location. Since August 1, 2018, the company has operated as a subsidiary of Mediware Information Systems, Inc.

Emplify

Series A in 2016
Emplify is a prominent software-as-a-service company specializing in employee engagement measurement. Founded in 2010 and based in Fishers, Indiana, Emplify provides a platform that allows executives to solicit, analyze, and act upon employee feedback, effectively translating data insights into actionable strategies. The company employs scientific methodologies and psychometrics to enhance workplace engagement. Emplify distinguishes itself by integrating survey insights with employee communication and performance improvement, creating a comprehensive engagement system designed to foster organizational transformation.

Euclises Pharmaceuticals

Venture Round in 2016
Euclises Pharmaceuticals, Inc. is engaged in the research, development, and commercialization of innovative medicines targeting inflammation and oncology. Founded in 2011 and headquartered in Saint Louis, Missouri, the company focuses on creating novel pain and cancer medications that promise enhanced safety profiles compared to current therapies. The firm is built on pioneering inventions by Dr. John Talley, a renowned medicinal chemist known for developing Celebrex among other approved drugs. Euclises aims to introduce new compounds that provide improved efficacy and safety, positioning itself as a leader in the pharmaceutical industry. The company operates from the BioGenerator Accelerator Labs, where it continues to advance its research initiatives.

Noonlight

Seed Round in 2016
Noonlight, Inc. is a company that specializes in personal safety through its mobile application, which connects various Internet of Things (IoT) devices to enhance user protection. Founded in 2013 and headquartered in Saint Louis, Missouri, Noonlight's platform provides 24/7 professional monitoring and data-driven emergency response capabilities. The application enables users to create accounts and connect multiple devices, allowing for precise location detection in emergencies. In critical situations, it can alert authorities without necessitating a 911 call or verbal communication. Noonlight's technology is operational across the United States, making it a versatile tool for enhancing personal safety and comfort.

Adarza BioSystems

Series B in 2016
Adarza BioSystems is an early-stage medical diagnostics company based in St. Louis, Missouri, founded in 2008. The company specializes in developing a rapid and label-free biological assay platform that measures clinical and point-of-care samples. This innovative platform employs diagnostic arrayed imaging reflectometry (AIR) to enable the simultaneous detection of hundreds of analytes from a single drop of fluid, allowing healthcare professionals to conduct sophisticated tests with high sensitivity and specificity. By significantly reducing the time required for testing, Adarza BioSystems aims to enhance diagnostic capabilities in various healthcare settings.

FinLocker

Seed Round in 2016
FinLocker, LLC is a financial technology company founded in 2014 and based in St. Louis, Missouri. It develops a consumer-enabled financial data platform that facilitates the loan process for mortgages and other financial products. The platform serves both businesses and consumers by streamlining loan transactions and enhancing the overall financial experience. For businesses, FinLocker provides tools that cut costs, reduce fraud, and mitigate risks while improving customer satisfaction and operational efficiency. For consumers, the platform simplifies the loan application process, minimizes paperwork, and enables better management of personal finances. Using consumer consent, FinLocker captures essential borrower data and employs intelligent analytics to offer tailored loan product recommendations based on individual financial profiles.

Label Insight

Series B in 2016
Label Insight, Inc. is a technology company that specializes in a cloud-based product data engine designed to help brands and retailers effectively manage their product information. Founded in 2004 and based in St. Louis, Missouri, with an additional office in Chicago and operations in Canada, the company collects and analyzes comprehensive data from product labels, including details on ingredients, allergens, nutrients, marketing claims, and certifications. This data is utilized by consumer packaged goods (CPG) brands, retailers, and other entities in the food industry to compare and analyze products across various categories such as food and beverage, apparel, personal care, and electronics. By transforming basic product data into insightful attributes, Label Insight enables its partners to unlock new growth opportunities and enhance consumer decision-making.

Euphrates Vascular

Venture Round in 2016
Euphrates Vascular is a medical technology company based in St. Louis, Missouri, focused on developing innovative solutions for the treatment of stroke, heart disease, and other related conditions. The company's flagship product, the magnetically-enhanced diffusion (MED) system, employs advanced magnet-based technology to accelerate the dissolution of blood clots, offering a faster delivery of FDA-approved clot-busting medications compared to traditional methods. This technology aims to significantly reduce mortality rates associated with strokes and heart disease. In addition to the MED system, Euphrates Vascular offers MED MicroBeads, which facilitate the rapid delivery of selected therapeutic agents to blood clots, and a touch screen-operated MED Workstation for enhanced user interaction. Founded by physicists with extensive experience in medical technology, the company continues to attract interest from investors and media for its groundbreaking contributions to cardiovascular care.

Label Insight

Venture Round in 2015
Label Insight, Inc. is a technology company that specializes in a cloud-based product data engine designed to help brands and retailers effectively manage their product information. Founded in 2004 and based in St. Louis, Missouri, with an additional office in Chicago and operations in Canada, the company collects and analyzes comprehensive data from product labels, including details on ingredients, allergens, nutrients, marketing claims, and certifications. This data is utilized by consumer packaged goods (CPG) brands, retailers, and other entities in the food industry to compare and analyze products across various categories such as food and beverage, apparel, personal care, and electronics. By transforming basic product data into insightful attributes, Label Insight enables its partners to unlock new growth opportunities and enhance consumer decision-making.

Euclises Pharmaceuticals

Venture Round in 2015
Euclises Pharmaceuticals, Inc. is engaged in the research, development, and commercialization of innovative medicines targeting inflammation and oncology. Founded in 2011 and headquartered in Saint Louis, Missouri, the company focuses on creating novel pain and cancer medications that promise enhanced safety profiles compared to current therapies. The firm is built on pioneering inventions by Dr. John Talley, a renowned medicinal chemist known for developing Celebrex among other approved drugs. Euclises aims to introduce new compounds that provide improved efficacy and safety, positioning itself as a leader in the pharmaceutical industry. The company operates from the BioGenerator Accelerator Labs, where it continues to advance its research initiatives.

BenchmarkONE

Seed Round in 2015
BenchmarkONE develops sales and marketing automation software tailored for small and mid-sized businesses. The company offers an integrated platform that includes customer relationship management (CRM) tools and sales automation features, allowing users to monitor contacts' activities, track deals, manage communications, and segment their audience. Additionally, BenchmarkONE provides email marketing capabilities with a user-friendly drag-and-drop email builder and marketing automation tools designed to engage visitors, prioritize leads, and optimize campaign investments. Originally known as Hatchbuck, Inc., the company rebranded to BenchmarkONE in June 2020 and has been operational since 2010, with its headquarters in St. Louis, Missouri. As of September 2019, BenchmarkONE functions as a subsidiary of Benchmark Internet Group, LLC.

Label Insight

Convertible Note in 2015
Label Insight, Inc. is a technology company that specializes in a cloud-based product data engine designed to help brands and retailers effectively manage their product information. Founded in 2004 and based in St. Louis, Missouri, with an additional office in Chicago and operations in Canada, the company collects and analyzes comprehensive data from product labels, including details on ingredients, allergens, nutrients, marketing claims, and certifications. This data is utilized by consumer packaged goods (CPG) brands, retailers, and other entities in the food industry to compare and analyze products across various categories such as food and beverage, apparel, personal care, and electronics. By transforming basic product data into insightful attributes, Label Insight enables its partners to unlock new growth opportunities and enhance consumer decision-making.

BlueStrata EHR

Seed Round in 2015
BlueStrata EHR is a St. Louis-based company that specializes in developing a cloud-based electronic health records (EHR) software platform tailored for long-term care and resident care facilities. The platform integrates clinical, financial, and point-of-care services, facilitating seamless data sharing across medical records and billing systems. BlueStrata EHR's intuitive design incorporates easily accessible touch screen kiosks, allowing caregivers to capture accurate resident care information from any location. Since August 1, 2018, the company has operated as a subsidiary of Mediware Information Systems, Inc.

Arch Oncology

Venture Round in 2015
Arch Oncology, Inc. is an immuno-oncology company focused on discovering and developing antibody therapeutics for the treatment of solid tumors and hematologic cancers. Established in 2006 and headquartered in Brisbane, California, with a research laboratory in St. Louis, Missouri, the company specializes in anti-CD47 antibodies that represent a novel class of checkpoint inhibitors. These second-generation antibodies are designed to engage both the adaptive and innate immune systems, effectively targeting and killing tumor cells. By harnessing the body's immune response, Arch Oncology aims to provide new treatment options for patients battling cancer.

Tunespeak

Series A in 2015
Tunespeak, LLC operates a musician-to-fan loyalty platform that rewards users for engaging with music and related content. Founded in 2011 and based in St. Louis, Missouri, the platform allows users to earn points by listening to music, watching videos, viewing photos, and sharing content with friends. Users can accumulate points not only for their own activity but also for enabling their friends to participate in contests or raffles for every song, picture, and video shared. Through this unique engagement model, Tunespeak aims to enhance the connection between musicians and their fans while offering incentives such as tickets, experiences, and merchandise.

Emplify

Venture Round in 2015
Emplify is a prominent software-as-a-service company specializing in employee engagement measurement. Founded in 2010 and based in Fishers, Indiana, Emplify provides a platform that allows executives to solicit, analyze, and act upon employee feedback, effectively translating data insights into actionable strategies. The company employs scientific methodologies and psychometrics to enhance workplace engagement. Emplify distinguishes itself by integrating survey insights with employee communication and performance improvement, creating a comprehensive engagement system designed to foster organizational transformation.

Covercress

Series A in 2015
CoverCress Inc. is a biotechnology company based in St. Louis, Missouri, focused on developing and commercializing field pennycress as an oilseed crop. Founded in 2013, the company aims to produce oil for industrial and renewable fuels, as well as meal for nutritious livestock feed. CoverCress specializes in crop breeding services that enhance soil cover during corn harvest and soybean planting, allowing farmers to maximize yields through sustainable agricultural practices. The company is dedicated to utilizing low-input methods to create a feedstock for low carbon intensity biofuels, contributing to more efficient and environmentally friendly agricultural solutions.

BenchmarkONE

Venture Round in 2015
BenchmarkONE develops sales and marketing automation software tailored for small and mid-sized businesses. The company offers an integrated platform that includes customer relationship management (CRM) tools and sales automation features, allowing users to monitor contacts' activities, track deals, manage communications, and segment their audience. Additionally, BenchmarkONE provides email marketing capabilities with a user-friendly drag-and-drop email builder and marketing automation tools designed to engage visitors, prioritize leads, and optimize campaign investments. Originally known as Hatchbuck, Inc., the company rebranded to BenchmarkONE in June 2020 and has been operational since 2010, with its headquarters in St. Louis, Missouri. As of September 2019, BenchmarkONE functions as a subsidiary of Benchmark Internet Group, LLC.

Euclises Pharmaceuticals

Series A in 2015
Euclises Pharmaceuticals, Inc. is engaged in the research, development, and commercialization of innovative medicines targeting inflammation and oncology. Founded in 2011 and headquartered in Saint Louis, Missouri, the company focuses on creating novel pain and cancer medications that promise enhanced safety profiles compared to current therapies. The firm is built on pioneering inventions by Dr. John Talley, a renowned medicinal chemist known for developing Celebrex among other approved drugs. Euclises aims to introduce new compounds that provide improved efficacy and safety, positioning itself as a leader in the pharmaceutical industry. The company operates from the BioGenerator Accelerator Labs, where it continues to advance its research initiatives.

CardiaLen

Series B in 2015
CardiaLen, Inc. is a medical device company based in Minneapolis, Minnesota, specializing in the development of innovative therapies for atrial fibrillation and other heart arrhythmias. Founded in 2008, the company is focused on creating implantable, low-energy cardioverter devices that offer pain-free cardioversion therapies. These devices monitor the heartbeat and employ a proprietary series of low-energy pulses to restore normal heart rhythm while minimizing discomfort and preventing damage to heart tissue. By addressing significant unmet needs in the treatment of atrial fibrillation, CardiaLen aims to enhance patient outcomes and reduce reliance on high-energy defibrillation shocks.

ImmunoPhotonics

Series A in 2015
ImmunoPhotonics, Inc. is a biotechnology company focused on developing innovative immunotherapy treatments for cancer, specifically targeting metastatic solid tumors. Founded in 2008 and located in Columbia, Missouri, the company has created a proprietary drug product designed to function as a minimally invasive therapeutic cancer vaccine. This product is administered through intratumoral injection following tumor ablation, leveraging tumor-associated neoantigens to stimulate a systemic anti-tumor immune response. By transforming the process of tumor ablation into a therapeutic approach, ImmunoPhotonics aims to enhance treatment options for patients with late-stage metastatic cancers. The company has also established a strategic partnership with Veterinary Cancer Therapeutics, LLC to further its mission in cancer treatment.

Label Insight

Series A in 2014
Label Insight, Inc. is a technology company that specializes in a cloud-based product data engine designed to help brands and retailers effectively manage their product information. Founded in 2004 and based in St. Louis, Missouri, with an additional office in Chicago and operations in Canada, the company collects and analyzes comprehensive data from product labels, including details on ingredients, allergens, nutrients, marketing claims, and certifications. This data is utilized by consumer packaged goods (CPG) brands, retailers, and other entities in the food industry to compare and analyze products across various categories such as food and beverage, apparel, personal care, and electronics. By transforming basic product data into insightful attributes, Label Insight enables its partners to unlock new growth opportunities and enhance consumer decision-making.

Adarza BioSystems

Series A in 2014
Adarza BioSystems is an early-stage medical diagnostics company based in St. Louis, Missouri, founded in 2008. The company specializes in developing a rapid and label-free biological assay platform that measures clinical and point-of-care samples. This innovative platform employs diagnostic arrayed imaging reflectometry (AIR) to enable the simultaneous detection of hundreds of analytes from a single drop of fluid, allowing healthcare professionals to conduct sophisticated tests with high sensitivity and specificity. By significantly reducing the time required for testing, Adarza BioSystems aims to enhance diagnostic capabilities in various healthcare settings.

Euclises Pharmaceuticals

Series A in 2014
Euclises Pharmaceuticals, Inc. is engaged in the research, development, and commercialization of innovative medicines targeting inflammation and oncology. Founded in 2011 and headquartered in Saint Louis, Missouri, the company focuses on creating novel pain and cancer medications that promise enhanced safety profiles compared to current therapies. The firm is built on pioneering inventions by Dr. John Talley, a renowned medicinal chemist known for developing Celebrex among other approved drugs. Euclises aims to introduce new compounds that provide improved efficacy and safety, positioning itself as a leader in the pharmaceutical industry. The company operates from the BioGenerator Accelerator Labs, where it continues to advance its research initiatives.

ImmunoPhotonics

Series A in 2014
ImmunoPhotonics, Inc. is a biotechnology company focused on developing innovative immunotherapy treatments for cancer, specifically targeting metastatic solid tumors. Founded in 2008 and located in Columbia, Missouri, the company has created a proprietary drug product designed to function as a minimally invasive therapeutic cancer vaccine. This product is administered through intratumoral injection following tumor ablation, leveraging tumor-associated neoantigens to stimulate a systemic anti-tumor immune response. By transforming the process of tumor ablation into a therapeutic approach, ImmunoPhotonics aims to enhance treatment options for patients with late-stage metastatic cancers. The company has also established a strategic partnership with Veterinary Cancer Therapeutics, LLC to further its mission in cancer treatment.

BenchmarkONE

Seed Round in 2014
BenchmarkONE develops sales and marketing automation software tailored for small and mid-sized businesses. The company offers an integrated platform that includes customer relationship management (CRM) tools and sales automation features, allowing users to monitor contacts' activities, track deals, manage communications, and segment their audience. Additionally, BenchmarkONE provides email marketing capabilities with a user-friendly drag-and-drop email builder and marketing automation tools designed to engage visitors, prioritize leads, and optimize campaign investments. Originally known as Hatchbuck, Inc., the company rebranded to BenchmarkONE in June 2020 and has been operational since 2010, with its headquarters in St. Louis, Missouri. As of September 2019, BenchmarkONE functions as a subsidiary of Benchmark Internet Group, LLC.

Adarza BioSystems

Series A in 2014
Adarza BioSystems is an early-stage medical diagnostics company based in St. Louis, Missouri, founded in 2008. The company specializes in developing a rapid and label-free biological assay platform that measures clinical and point-of-care samples. This innovative platform employs diagnostic arrayed imaging reflectometry (AIR) to enable the simultaneous detection of hundreds of analytes from a single drop of fluid, allowing healthcare professionals to conduct sophisticated tests with high sensitivity and specificity. By significantly reducing the time required for testing, Adarza BioSystems aims to enhance diagnostic capabilities in various healthcare settings.

Wealth Access

Series A in 2014
Wealth Access, Inc. is a financial technology company that provides personal financial management tools tailored for registered investment advisors and their high net worth clients. Founded in 2011 and headquartered in Nashville, Tennessee, the company offers a proprietary cloud-based platform that facilitates wealth reporting and investment monitoring. This platform features an intuitive interface and advanced aggregation capabilities, managing data from over 20,000 financial institutions. By rendering complex global portfolios into a clear, real-time digital dashboard, Wealth Access enables financial advisors and their clients to navigate the wealth management landscape effectively. The company also has additional locations in St. Louis, Missouri; Dallas, Texas; New York, New York; and Tampa, Florida, serving the financial services sector.

Salesvue

Venture Round in 2014
Salesvue, LLC, founded in 2006 and based in Indianapolis, Indiana, provides salesforce automation software designed to enhance productivity for sales teams. Originally known as Jesubi, the company rebranded in 2013 to focus on its prospect-to-pipeline automation solution. Salesvue's software serves as a sales enablement tool for Salesforce.com users, addressing the often unstructured prospecting phase of the sales cycle. By employing empirical data, Salesvue enables strategic decision-making, enhancing the effectiveness of sales executives and managers alike. The platform facilitates collaboration among marketing, sales, and onboarding teams, streamlining communication and accountability throughout the sales process. With its native Salesforce AppX solution, Salesvue helps organizations implement proven prospecting methodologies, aiming to boost a salesperson's daily calling throughput significantly while providing valuable analytics for sales management.

Euphrates Vascular

Venture Round in 2014
Euphrates Vascular is a medical technology company based in St. Louis, Missouri, focused on developing innovative solutions for the treatment of stroke, heart disease, and other related conditions. The company's flagship product, the magnetically-enhanced diffusion (MED) system, employs advanced magnet-based technology to accelerate the dissolution of blood clots, offering a faster delivery of FDA-approved clot-busting medications compared to traditional methods. This technology aims to significantly reduce mortality rates associated with strokes and heart disease. In addition to the MED system, Euphrates Vascular offers MED MicroBeads, which facilitate the rapid delivery of selected therapeutic agents to blood clots, and a touch screen-operated MED Workstation for enhanced user interaction. Founded by physicists with extensive experience in medical technology, the company continues to attract interest from investors and media for its groundbreaking contributions to cardiovascular care.

Tunespeak

Seed Round in 2013
Tunespeak, LLC operates a musician-to-fan loyalty platform that rewards users for engaging with music and related content. Founded in 2011 and based in St. Louis, Missouri, the platform allows users to earn points by listening to music, watching videos, viewing photos, and sharing content with friends. Users can accumulate points not only for their own activity but also for enabling their friends to participate in contests or raffles for every song, picture, and video shared. Through this unique engagement model, Tunespeak aims to enhance the connection between musicians and their fans while offering incentives such as tickets, experiences, and merchandise.

Label Insight

Seed Round in 2013
Label Insight, Inc. is a technology company that specializes in a cloud-based product data engine designed to help brands and retailers effectively manage their product information. Founded in 2004 and based in St. Louis, Missouri, with an additional office in Chicago and operations in Canada, the company collects and analyzes comprehensive data from product labels, including details on ingredients, allergens, nutrients, marketing claims, and certifications. This data is utilized by consumer packaged goods (CPG) brands, retailers, and other entities in the food industry to compare and analyze products across various categories such as food and beverage, apparel, personal care, and electronics. By transforming basic product data into insightful attributes, Label Insight enables its partners to unlock new growth opportunities and enhance consumer decision-making.

BenchmarkONE

Seed Round in 2012
BenchmarkONE develops sales and marketing automation software tailored for small and mid-sized businesses. The company offers an integrated platform that includes customer relationship management (CRM) tools and sales automation features, allowing users to monitor contacts' activities, track deals, manage communications, and segment their audience. Additionally, BenchmarkONE provides email marketing capabilities with a user-friendly drag-and-drop email builder and marketing automation tools designed to engage visitors, prioritize leads, and optimize campaign investments. Originally known as Hatchbuck, Inc., the company rebranded to BenchmarkONE in June 2020 and has been operational since 2010, with its headquarters in St. Louis, Missouri. As of September 2019, BenchmarkONE functions as a subsidiary of Benchmark Internet Group, LLC.

Euphrates Vascular

Series B in 2012
Euphrates Vascular is a medical technology company based in St. Louis, Missouri, focused on developing innovative solutions for the treatment of stroke, heart disease, and other related conditions. The company's flagship product, the magnetically-enhanced diffusion (MED) system, employs advanced magnet-based technology to accelerate the dissolution of blood clots, offering a faster delivery of FDA-approved clot-busting medications compared to traditional methods. This technology aims to significantly reduce mortality rates associated with strokes and heart disease. In addition to the MED system, Euphrates Vascular offers MED MicroBeads, which facilitate the rapid delivery of selected therapeutic agents to blood clots, and a touch screen-operated MED Workstation for enhanced user interaction. Founded by physicists with extensive experience in medical technology, the company continues to attract interest from investors and media for its groundbreaking contributions to cardiovascular care.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.